Severe genitourinary toxicity following radiation therapy for prostate cancer - How long does it last?

Journal of Urology

Volumn 189, Issue 1, 2013, Pages 116-121

  Kim, Sung ^a   Moore, Dirk F ^a,b   Shih, Weichung ^a,b   Lin, Yong ^a,b   Li, Hui ^a   Shao, Yu Hsuan ^a   Shen, Shunhua ^c   Lu Yao, Grace L ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c Smith Hanley Consultant Group   (United States)

Author keywords

prostate; prostatic neoplasms; radiotherapy; SEER program; toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; COHORT ANALYSIS; DISEASE SURVEILLANCE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH PROGRAM; HUMAN; INCOME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; UROGENITAL TRACT INJURY; UROGENITAL TRACT TOXICITY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; MALE; MALE UROGENITAL DISEASES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84870949940     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.091     Document Type: Article

References (19)

1. N. Mohammed, L. Kestin, M. Ghilezan Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer Int J Radiat Oncol Biol Phys 82 2012 204
2. J.L. Warren, C.N. Klabunde, D. Schrag Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 2002 IV-3
3. G.S. Cooper, Z. Yuan, K.C. Stange Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment Med Care 38 2000 411
4. E.B. Lamont, D.S. Lauderdale, R.L. Schilsky et al. Construct validity of medicare chemotherapy claims: the case of 5FU Med Care 40 2002 201
5. G.S. Cooper, B. Virnig, C.N. Klabunde Use of SEER-Medicare data for measuring cancer surgery Med Care 40 2002 IV-43
6. B.A. Virnig, J.L. Warren, G.S. Cooper Studying radiation therapy using SEER-Medicare-linked data Med Care 40 2002 IV-49
7. G.L. Lu-Yao, P.C. Albertsen, D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202
8. P. Diggle, P. Heagerty, K.-Y. Liang Analysis of Longitudinal Data 2002 Oxford University Press-USA New York
9. H. Putter, M. Fiocco, R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389
10. B. Efron, R. Tibshirani An Introduction to the Bootstrap 1994 Chapman & Hall New York
11. J.C. Blasko, H. Ragde, P.D. Grimm Transperineal ultrasound-guided implantation of the prostate: morbidity and complications Scand J Urol Nephrol 137 Suppl 1991 113
12. D.Y. Gelblum, L. Potters, R. Ashley Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 145 1999 59
13. L. Budäus, M. Bolla, A. Bossi Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature Eur Urol 61 2012 112
14. J.A. Talcott, J.A. Clark, P.C. Stark Long-term treatment related complications of brachytherapy for early prostate cancer J Urol 166 2001 494
15. H.L. Luo, F.M. Fang, Y.C. Chuang Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer BJU Int 104 2009 1620
16. K. Odrazka, M. Dolezel, J. Vanasek Late toxicity after conformal and intensity-modulated radiation therapy for prostate cancer: impact of previous surgery for benign prostatic hyperplasia Int J Urol 17 2010 784
17. W.D. Heemsbergen, A. Al-Mamgani, M.G. Witte Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics Int J Radiat Oncol Biol Phys 78 2010 19
18. A.S. Sandhu, M.J. Zelefsky, H.J. Lee Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection Int J Radiat Oncol Biol Phys 48 2000 643
19. Z.A. Alicikus, Y. Yamada, Z. Zhang Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer Cancer 117 2011 1429